Clinical Trial Update: Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

Phase 1/1b study of nab-sirolimus for severe pulmonary arterial hypertension has completed, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• nab-sirolimus (sirolimus (nanoparticle albumin-bound formulation))

Snippet

Sponsor: Aadi Bioscience, Inc. | Conditions: Pulmonary Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2024-11-25